Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd
* Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor
Source text in Chinese: goo.gl/KA8dec
Further company coverage: (Beijing Headline News)
 